David Shaw’s Viela Bio, Inc. Common Stock VIE Stock Holding History

David Shaw’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-29,638	Closed	-$805K	–	4411
2019 Q4	$805K	Buy	+29,638	New	+$747K	﹤0.01%	3126

Other funds holding VIE

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

David Shaw's VIE Position: Q1 2020 in Review

David Shaw sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2020, closing a stake of 29,638 shares — an estimated $805K sold.

David Shaw first reported a position in VIE in Q4 2019 and held it in 1 quarter. The position peaked at $805K in Q4 2019. 47 funds tracked by Wall St. Rank hold VIE as of Q1 2020.

David Shaw reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
David Shaw sold 29,638 Viela Bio, Inc. Common Stock shares in Q1 2020, an estimated $805K.
David Shaw first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
David Shaw's Viela Bio, Inc. Common Stock position peaked at $805K in Q4 2019.
47 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.